| 0.085 -0.007 (-7.61%) | 01-15 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.15 | 1-year : | 0.21 |
| Resists | First : | 0.13 | Second : | 0.18 |
| Pivot price | 0.07  |
|||
| Supports | First : | 0.05 | Second : | 0.04 |
| MAs | MA(5) : | 0.09 |
MA(20) : | 0.07 |
| MA(100) : | 0.1 |
MA(250) : | 1.37 |
|
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 29.5 |
D(3) : | 36.8 |
| RSI | RSI(14): 50.2 |
|||
| 52-week | High : | 3.92 | Low : | 0.05 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ CDT ] has closed below upper band by 39.6%. Bollinger Bands are 72.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 0.09 - 0.09 | 0.09 - 0.09 |
| Low: | 0.08 - 0.08 | 0.08 - 0.08 |
| Close: | 0.08 - 0.09 | 0.09 - 0.09 |
Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.
Tue, 14 Jan 2025
Conduit Pharmaceuticals secures stockholder approval - Investing.com
Fri, 10 Jan 2025
Nasdaq Down Over 2%; Walgreens Posts Upbeat Results - Benzinga
Fri, 10 Jan 2025
Dow Dips 500 Points; US Economy Adds 256,000 Jobs In December - Benzinga
Tue, 07 Jan 2025
Pre-market Movers: CDT, NARI, GDTC, NARI... - RTTNews
Thu, 21 Nov 2024
What's Going On With Conduit Pharmaceuticals Shares Today? - Benzinga
Thu, 21 Nov 2024
Conduit Pharma Secures Key Patent for Autoimmune Drug AZD1656 in Major Japan Market - StockTitan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 120 (M) |
| Shares Float | 54 (M) |
| Held by Insiders | 49.1 (%) |
| Held by Institutions | 4 (%) |
| Shares Short | 3,570 (K) |
| Shares Short P.Month | 1,450 (K) |
| EPS | -0.24 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.01 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -322.1 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -9 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -0.37 |
| PEG Ratio | 0 |
| Price to Book value | -8.5 |
| Price to Sales | 0 |
| Price to Cash Flow | -1.11 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|